Global
Coronary Stents Market: Description
This
report studies the current as well as future prospects of the
coronary stents market globally. At present, there are several
individuals around the world who require percutaneous coronary
interventions (PCIs) due some form of coronary artery diseases
(CADs), such as angina pectoris and acute myocardial infarction,
regardless of their gender, age or geographic location. There are
various types of coronary stents currently available worldwide, which
are utilized during PCIs for treating CADs. Coronary stents are
tubular structures, which are majorly made of thin mesh of metal
wires, and many a time covered with a biodegradable material that
contains the drug. However, at present whole stents that are made of
a biodegradable material that wholly gets absorbed in the tissues
over time are also available in the global market. This report
comprises an elaborate executive summary, which includes a market
snapshot that provides overall information of various segments and
sub-segments that are contained in the report. It also provides an
overall information and data analysis of the global coronary stents
market with respect to market segments based on product type as well
as geographic regions.
The
market for coronary stents is categorized into three major segments,
namely, bare metal stents (BMS), drug eluting stents (DES) and
bio-absorbable stents. Each of the market segments has been
extensively analyzed based on their commercial existence, efficacy,
sales revenue and geographic presence. The market size and forecast
in terms of USD million for each product type has been provided for
the period 2011 to 2019. The report also provides compounded annual
growth rate (CAGR %) for each market segment for the forecast period
2013 to 2019, considering 2012 as the base year.
Browse
Market Research
Report:
http://www.transparencymarketresearch.com/coronary-stents-market.html
http://www.transparencymarketresearch.com/coronary-stents-market.html
Coronary
Stents Market:
Segment
The
market for coronary stents can be broadly classified into three major
segments, namely, bare metal stents (BMS), drug eluting stents (DES)
and bio-absorbable stents. In 2011, the drug eluting stents segment
held the largest share of the global coronary stents market, followed
by the bare metal stents market. During the forecast period 2013 to
2019, the demand for bare metal stents is expected to be low and its
overall growth will be offset by the increasing demand for other
stent variants, mainly bio-absorbable stents. The bio-absorbable
stents market has been predicted to be the fastest growing segment
during the forecast period.
Some
of the major factors that will be responsible for the growth of
global coronary stents market during the forecast period include
increasing prevalence of various coronary artery diseases, rising
demand for new and advanced coronary stents, aging population and
increasing obesity rates. According to World Health Organization
(WHO) estimates, around 17.3 million people died from cardiovascular
diseases in 2008 and it is expected that each year more than 23.3
million people will die due to cardiovascular diseases; this trend is
predicted to continue till 2030. Among cardiovascular diseases, CADs
are responsible for the highest number of deaths worldwide. However,
according to the CDC, U.S., the number of deaths due to CADs has
started decreasing due to increase in the number of PCIs being
performed by using a range of coronary stents available in the global
market.
North
America holds the largest share in the global coronary stents market
in terms of revenue. The key factor responsible for the dominance of
this region in the global coronary stents market was that the top
players of this market are domiciled in the U.S., where they
introduce their product and gain early-bird advantage in the market.
Europe is the second largest market for coronary stents, followed by
Asia-Pacific. The Asia-Pacific region is expected to be the fastest
growing regional market for coronary stents. The market growth in
this region will be majorly attributed to the increasing incidences
of various CADs, high unmet needs of the patient pool, increasing
awareness as well as affordability of the patient population of this
region and increasing penetration by U.S. and Europe-based coronary
stent manufacturers.
Fill
the form for an exclusive sample of this report:
No comments:
Post a Comment